CVS Caremark awarded three-year FEP contract
WOONSOCKET, R.I. — CVS Caremark has been awarded a three-year contract to provide integrated PBM for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program.
The company stated that it will continue to provide retail PBM services, mail service pharmacy, specialty pharmacy services and highly customized clinical programs to FEP’s more than 5 million federal employees, retirees and dependents. The new agreement, which runs through 2017, brings the relationship between CVS Caremark and FEP to more than 20 years.
"FEP is a highly valued client and we are committed to delivering the same high level of service and patient satisfaction that we have provided to FEP’s federal employees, retirees and their families for many years," stated Jon Roberts, president of the CVS Caremark PBM business. "We are pleased that FEP continues to recognize the value and services that CVS Caremark provides to their plan and members."
Perrigo launches store brand adult nutritional line
DUBLIN — Perrigo on Wednesday announced that its Nutritionals segment is partnering with KanPak to manufacture store brand adult nutritional drinks comparable to Ensure products. KanPak is a supplier of beverages and desserts using aseptic processing technology.
In 2013 Golden State Foods, one of the largest diversified food processors and distributors in the United States, acquired a controlling interest in KanPak. Perrigo will supply retailers with six store brand versions of the six nutritional drinks currently sold in the Ensure line. The adult nutritional drink market represents $900 million in annual branded sales for the last 12 months, as measured by SymphonyIRI Group.
"Our nutritionals team already supplies leading retailers with a range of nutritionals, from infant formula to adult vitamins, so this is a logical extension for our business," stated Joseph Papa, Perrigo chairman, president and CEO. "We made a significant investment into this partnership to bring quality, affordable healthcare products to retailers and the adult consumers they serve across the United States."
Study: A1C test not a reliable predictor of heart disease
CHICAGO — In a study that included nearly 300,000 adults without a known history of diabetes or cardiovascular disease, adding information about glycated hemoglobin (HbA1c), a measure of longer-term blood sugar control, to conventional CVD risk factors like smoking and cholesterol was associated with little improvement in the prediction of CVD risk, according to a study in the March 26 issue of JAMA.
Because higher glucose levels have been associated with higher CVD incidence, it has been proposed that information on blood sugar control might improve doctors’ ability to predict who will develop CVD, according to background information in the article.
Among the primary findings of the researchers, adding information on levels of HbA1c to conventional CVD risk factors was associated with only slight improvement in risk discrimination (how well a statistical model can separate individuals who do and do not go on to develop CVD). In addition, they found that adding information on HbA1c did not improve the accuracy of probability predictors for patients with and without CVD.